Learn More
Medchemexpress LLC 6-[3,4-dihydroxy-pyrrolid-1-yl]-2-[3-hydroxy-3-methyl-pyrrolid-1-yl]-4-(CF3)pyridine-3-carbonitrile | 2135304-43-5 | 99.1% | 372.34 g·mol⁻1 | C16H19F3N4O3 | 100 MG

Supplier: Medchemexpress LLC HY103478100MG
KHK-IN-2 is a potent and selective ketohexokinase (KHK) inhibitor with a reported IC50 of 0.45 μM, supplied as a high-purity small-molecule research compound suitable for enzymatic, cell-based, and in vivo studies.
- Potent KHK inhibition with IC50 0.45 μM.
- High purity, approximately 99.05% by COA.
- Highly soluble in DMSO (stock solutions up to 250 mg/mL).
- Formulation guidance provided for in vivo dosing.
- Powder storage: -20°C (3 years) or 4°C (2 years); in solvent: -80°C (2 years).
- Datasheet, COA, SDS, and LCMS documentation available for verification.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.